This is the authors' abstract. We don't add key points for this paper.
Neonatal alloimmune thrombocytopenia can effectively be treated by transfusing compatible platelets to the affected newborn, but typed, compatible platelets are not generally available. For a case of probable neonatal alloimmune thrombocytopenia due to anti-HPA-1a, part of the donor population of the regional blood bank was phenotyped to find HPA-1a-negative platelets. A flow cytometric technique was used, which is reliable, rapid, and relatively simple and therefore well suited for large-scale screening. Using this method, several HPA-1a-negative donors were identified, and one of them donated platelets that were successfully transfused to the thrombocytopenic newborn.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hoffmann et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: